Companies /Healthcare

Cronos Group Inc

NASDAQ: CRON Drug Manufacturers - Specialty & Generic
$3.22
▼ $0.05 (−1.59%) today
Markets open · 12:56pm ET

CRON at a Glance

Valuation
Market cap
$1.2B
P/E ratio
20.4
Profitability
Revenue (TTM)
$206.2M
Profit margin
28.0%
EPS (TTM)
$0.16
Price
52-week range
$2 – $4
Street target
$2.95

Headquartered in Stayner, ON Fiscal year ends December NASDAQ: CRON thecronosgroup.com

About Cronos Group

Cronos Group is a global cannabis company that develops, produces and markets cannabis consumer products, emphasizing R&D, proprietary genetics and cultivation. It operates as one reportable segment and sells cannabis flower and cannabis extracts (vapes, edibles, pre-rolls and other formats).

- **Canada:** Its Spinach brand, including SOURZ by Spinach gummies and Spinach PUFFERZ all-in-one vapes, holds top national positions in vapes and edibles.
- **Israel:** The PEACE NATURALS medical cannabis brand is the market's top brand.
- **Germany and other international markets:** It sells medical cannabis flower, with Germany a fast-growing market.
- **Netherlands:** In October 2026 Cronos acquired CanAdelaar B.V., the leading operator in the Dutch adult-use cannabis pilot program.

Other brands include LIT, Lord Jones and C.O.G. The company controls Cronos GrowCo, a cultivation and processing facility operator, and runs the Peace Naturals Campus in Stayner, Ontario.

It also holds a junior secured convertible loan to and warrant in High Tide Inc., and equity securities in Vitura Health. Altria Group is a significant investor. The company holds a substantial cash and investment balance and returns capital through share repurchases. Updated

Latest Activity

CRONCronos Group
Q3 2026
EPS
$0.04
est $0.05-$0.01
Revenue
$63M
est $73M-13.6%

Revenue grew 74.6% year over year and still came in under consensus, with both EPS and the top line missing expectations. Sales outside Israel and Canada jumped 614%, led by Germany, and the Dutch adult-use market opens up now that CanAdelaar closed in October. Keep an eye on the stock as that growth narrative meets a second straight quarter of estimates running ahead of results.

Quarterly EPS — reported vs estimate

CRON Coverage

Frequently Asked Questions

What does Cronos Group do?

Cronos Group is a global cannabis company that develops, produces and markets cannabis consumer products, emphasizing R&D, proprietary genetics and cultivation.

What is the CRON stock price target?

The Wall Street consensus 12-month price target for CRON is $2.95.